Table 2 Expression of IGFBP3 and RXRalpha in Prostatic Epithelium

IGFBP3

Positive cases

105

62

49

202

25

Negative cases

5

1

9

36

8

Statistics (comparison)

p = 0.0036 (cancer)

N.S. (cancer)

p = 0.0044 (normal)

N.S. (cancer)

IGFBP3

Intensity (avg+/-std)

2.47 +/- 0.70

2.49 +/- 0.65

2.57 +/- 0.82

2.74 +/- 0.56

2.79 +/- 0.49

Percentage cells (avg+/- std)

8.3 +/- 13.5

7.5 +/- 12.5

8.8 +/- 15.2

4.4 +/- 6.6

8.5 +/- 12.6

Nuclear cases

92

59

40

94

8

Cytoplasmic cases

22

6

18

152

11

Statistics (comparison)

p < 0.00001 (cancer)

p = 0.065 (cancer)

p < 0.00001 (normal)

N.S. (cancer)

RXRalpha

Positive cases

92

58

35

112

16

Negative cases

10

3

31

125

19

Statistics (comparison)

p < 0.00001 (cancer)

N.S. (cancer)

p < 0.00001 (normal)

N.S. (cancer)

RXRalpha

Intensity (avg+/-std)

2.73 +/- 0.51

2.78 +/- 0.50

2.83 +/- 0.38

2.76 +/- 0.49

3 +/- 0

Percentage cells (avg+/- std)

20.0 +/- 25.5

23.2 +/- 25.7

8.4 +/- 12.5

8.6 +/- 12.6

4.2 +/- 4.6

Nuclear cases

92

58

35

107

16

Cytoplasmic cases

2

0

6

9

0

Statistics (comparison)

N.S. (cancer)

N.S. (cancer)

N.S. (normal)

N.S. (cancer)